Impeto Medical
Latest round
- Series B
Last raised
- Jul 2013
Total raised
- $8M
Investors
- 3
About Impeto Medical
Founded in 2005 and headquartered in Paris, France, Impeto Medical focuses on innovating medical devices for nerve evaluation. The company was acquired in January 2022 by Withings SACA from Oddo BHF Private Assets and Seventure Partners. The acquisition presents opportunities to enhance the Sudoscan technology, both domestically and internationally.Impeto Medical’s primary product offering is the SUDOSCAN device, an innovative medical device designed for the early detection and management of autonomic and small fiber neuropathies. This system functions by stimulating sweat glands to evaluate small nerve fibers within the peripheral nervous system, providing an accurate assessment of sudomotor function in under three minutes. The device employs a computer interface alongside four electrodes where patients place their hands and bare feet to facilitate the test. SUDOSCAN is utilized in various clinical settings, particularly in diabetes management, oncology for quantifying chemotherapy-induced polyneuropathy, and nephrology for monitoring peripheral autonomic neuropathies.Impeto Medical generates revenue through the sales of its SUDOSCAN devices, which are classified as Class IIa medical devices and cleared for use by the FDA and CE certified. The company engages in direct sales to healthcare facilities, clinics, and hospitals, where practitioners utilize the SUDOSCAN device for patient evaluations and follow-ups. The revenue model is primarily based on one-time purchases of the device, with potential recurring revenue from consumables or maintenance agreements. Additionally, partnerships with healthcare organizations and distribution agreements in various international markets enhance the company’s reach and profitability.Impeto Medical plans to leverage the recent acquisition by Withings to further develop the SUDOSCAN technology, enhancing its capabilities and expanding its market presence. The company is targeting additional international markets for its SUDOSCAN device, with a focus on regions not yet fully penetrated.147 mn, will be allocated to support these growth initiatives, enhancing product development and market outreach strategies.
Who invested in Impeto Medical
3 investors across 2 rounds
See all investors in Impeto Medical
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Impeto Medical
Who invested in Impeto Medical?
Impeto Medical has 3 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Impeto Medical raised?
Impeto Medical has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Impeto Medical last raise money?
Impeto Medical's most recent round on record is a Series B, in Jul 2013.
What does Impeto Medical do?
Founded in 2005 and headquartered in Paris, France, Impeto Medical focuses on innovating medical devices for nerve evaluation.
Where is Impeto Medical headquartered?
Impeto Medical is headquartered in Paris, France.
Which VCs invest in companies like Impeto Medical?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back medical devices & equipment companies at Impeto Medical's stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Series B
Raising like Impeto Medical? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.